Home Sentonix

Sentonix

In operation
Debt Financing
Biopharmaceutical R&D Company for Neurodegenerative Diseases
Basic
Enterprise Profile

Basic Information

Sentonix is an emerging biopharmaceutical company. The company focuses on areas such as cancer immunotherapy and currently concentrates on Parkinson's disease, Alzheimer's disease, and other neurodegenerative disease fields, committing to the early discovery and clinical translation of next-generation innovative drugs.
Sentonix, Inc.
Arlington,Massachusetts,United States of America
unclear
January 01, 2023
--
--

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products
Technology
Immunological Techniques
Concept
Neurology Department Oncology Department Disease Treatment Tumor # Nervous System Diseases
Application Scenarios
Innovative Drugs Biological Products